Prenatal administration of heparin-binding epidermal growth factor-like growth factor in an experimental model of necrotizing enterocolitis decreased both incidence and severity of the disease
Saved in:
Main Authors: | Yomara Stephanie Mendez (Author), Faraz A Khan (Author), Andrei Radulescu (Author), Marla Ashley Sacks (Author), Robert Propst (Author), Craig W Zuppan (Author), Christopher G Wilson (Author) |
---|---|
Format: | Book |
Published: |
BMJ Publishing Group,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Animal models of necrotizing enterocolitis
by: Yomara Stephanie Mendez, et al.
Published: (2020) -
Trisomy 18 and necrotizing enterocolitis
by: Alexandra Maidan, et al.
Published: (2022) -
Epidermal growth factor as a reliable marker of necrotizing enterocolitis in preterm neonates
by: Na Mi Lee
Published: (2020) -
The higher heparin-binding epidermal growth factor (HB-EGF) in missed abortion
by: Kemal Ozbilgin, et al.
Published: (2015) -
The relation between serum levels of epidermal growth factor and necrotizing enterocolitis in preterm neonates
by: Heba Mostafa Ahmed, et al.
Published: (2019)